$47.78 (0.0628%)

Volume: 282.59k

Closed: Jan 27, 2023

Hollow Logo Score: 1.207
Blueprint Medicines Corporation Stock
$47.78 (0.0628%)

Volume: 282.59k

Closed: Jan 27, 2023

Score Hollow Logo 1.207
NASDAQ:BPMC

Blueprint Medicines Corporation Stock Predictions

Currently predicting for Mon, 30 Jan 2023

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 48.59 1.70 %
R2 48.21 0.91 %
R1 47.98 0.414 %
Current price: 47.78
Support S1 47.22 -1.18 %
S2 46.98 -1.67 %
S3 46.60 -2.46 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 53.04 11.01 %
R2 50.19 5.04 %
R1 48.24 0.96 %
Current price 47.78
Support S1 46.60 -2.47%
S2 46.10 -3.52%
S3 45.22 -5.36%

BPMC Predictions History

3 years ago
NameNotImportant predicted that BPMC for 2019-05-03 is going $78.05 (-1.75%)

3 years ago
zsyontekleri predicted that BPMC for 2019-04-08 is going $84.11 (1.08%)

Rank:

Hot Stocks To Watch:

About Blueprint Medicines Corporation

Blueprint Medicines Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibitor for the treatment of non-advanced SM and other mast cell disorders; and Fisogatinib, an orally avail... BPMC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT